Flomenberg Neal 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Flomenberg Neal（CIK 2011757）在 1 家公司共报告 4 笔 SEC Form 4 内部人交易（最近一笔 2026-03-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 19 | $147 |
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 452 | $3,282 |
| 2026-03-17 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | 卖出 | 501 | $3,206 |
| 2025-07-01 | Tevogen Bio Holdings Inc. (TVGN) | Chief Scientific Officer, Global R&D Lead | 买入 | 300,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-17